Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
      • Research Guidelines
        • Minimum Information About Microarray Data Experiments (MIAME)
      • Abstract
      • Acknowledgments
      • Clinical Implications (Only by invitation)
      • Conflict(s) of Interest/Disclosure(s) Statement
      • Figure Legends
      • Figures
      • Novelty and Significance: 1) What Is New, 2) What Is Relevant?
      • References
      • Sources of Funding
      • Tables
      • Text
      • Title Page
      • Online/Data Supplement
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
      • Change of Authorship Form
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Hypertension

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Epidemiology/Population Studies

Serum Anion Gap and Blood Pressure in the National Health and Nutrition Examination Survey

Eric N. Taylor, John P. Forman, Wildon R. Farwell
Download PDF
https://doi.org/10.1161/HYPERTENSIONAHA.107.092643
Hypertension. 2007;50:320-324
Originally published July 18, 2007
Eric N. Taylor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John P. Forman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wildon R. Farwell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading

Abstract

Increased production of organic acid can result in an elevated serum anion gap and may play a role in the development of hypertension. We studied the cross-sectional associations between anion gap and blood pressure and between serum bicarbonate and blood pressure in the 1999-2000 and 2001-2002 National Health and Nutrition Examination Surveys. We included 5043 adult participants who were not taking antihypertensive medications or diuretics and who denied hypertension, cardiovascular disease, diabetes, and other diseases. Linear regression was used to adjust for age, race, body mass index, creatinine, albumin, and other factors. Sample weights were used to produce weighted regression parameters. In the lowest quintile of anion gap, mean values of sodium, chloride, and bicarbonate were 139 mEq/L, 105 mEq/L, and 25 mEq/L, respectively. In the highest quintile, mean values of sodium, chloride, and bicarbonate were 140 mEq/L, 101 mEq/L, and 22 mEq/L, respectively. Mean blood pressure was 118/72 mm Hg. After multivariable adjustment, participants in the highest quintile of anion gap had systolic blood pressure 3.73 mm Hg higher (95% CI: 1.83 to 5.63 mm Hg; P for trend: <0.01) than participants in the lowest quintile. Participants in the highest quintile of bicarbonate had systolic blood pressure 2.73 mm Hg lower (95% CI: 1.26 to 4.20 mm Hg; P for trend: <0.01) than participants in the lowest quintile. No associations were observed between anion gap or bicarbonate and diastolic blood pressure. The results were unchanged after excluding participants with estimated glomerular filtration rate <60 cc/min per 1.73 m2. The anion gap is independently associated with higher blood pressure. Further research is needed to elucidate the relation between organic acid and hypertension.

  • epidemiology
  • hypertension
  • anion gap
  • metabolic acidosis
  • NHANES

Hypertension affects >65 million individuals in the United States1,2 and is an important independent risk factor for cardiovascular disease3–6 and renal failure.7–9 The pathogenesis of hypertension is poorly understood and remains under active investigation. It has been suggested that increased production of organic acid may lead to the development of hypertension.10

Metabolic acidosis, increased renal acid excretion, and increased metabolic production of acid have been reported in rat models of hypertension and in salt-sensitive humans. For example, plasma pH and bicarbonate were lower in spontaneously hypertensive rats than in normotensive controls.11,12 Metabolic acidosis preceded the development of hypertension in the hypertensive rats, suggesting that the acid-base changes were not the product of elevated blood pressure or associated renal insufficiency.12 Metabolic studies of rats on both high- and low-salt diets have demonstrated increased urinary acid excretion in salt-sensitive compared with salt-resistant rats.13 Of note, the higher levels of acid excretion in the salt-sensitive rats appeared to be because of increased metabolic production of acid.13 Analogous results have been reported in salt-sensitive humans.14,15

The results of a recent study analyzing the 24-hour excretion of urinary citrate in >3000 men and women are consistent with the hypothesis that higher levels of organic acid production may be related to high blood pressure. The excretion of urinary citrate is regulated most prominently by acid-base status, with acidosis resulting in a marked reduction in citrate excretion.16 After adjustment for age, body mass index (BMI), diet, and other urinary factors, participants with hypocitraturia were 2.5 times more likely to have prevalent hypertension than those without hypocitraturia.17

To date, there have been no population-based studies of acid-base status and blood pressure. An increase in unmeasured anions, as seen in many causes of metabolic acidosis, results in an elevated serum anion gap. We examined the associations between serum anion gap and blood pressure and between serum bicarbonate and blood pressure in the 1999–2000 and 2001–2002 National Health and Nutrition Examination Surveys (NHANES).

Methods

Study Population

We studied participants in NHANES 1999–2000 and 2001–2002. The design and operation of NHANES has been described previously (data downloaded from http://www.cdc.gov/nchs/about/major/nhanes/nhanes99_00.htm and http://www.cdc.gov/nchs/about/major/nhanes/nhanes01-02.htm).18,19 Briefly, NHANES provides nationally representative cross-sectional data on the health status of the civilian, noninstitutionalized US population. After selection in a complex survey design, participants were interviewed and examined. Participants over the age of 12 years without hemophilia or recent cancer chemotherapy were eligible for measurement of a biochemistry profile that included serum chemistries and creatinine. In the interview, participants were asked about their medical history, including the presence or absence of health professional–diagnosed hypertension, kidney disease, diabetes mellitus, congestive heart failure, coronary heart disease, angina, myocardial infarction, stroke, cancer, and other diseases. Participants were also queried about the use of specific medications, including antihypertensive medications and diuretics. Participants were defined as current smokers if they reported that they were currently smoking and had smoked ≥100 cigarettes in their entire life. A dietary interview collected data for estimating the daily intake of dietary factors, including total protein and potassium, on the basis of foods and beverages that participants consumed during the 24-hour period preceding the interview (midnight to midnight).

Measurement of Serum Electrolytes and Creatinine

Serum electrolytes, albumin, and creatinine were measured with a Hitachi Model 704 multichannel analyzer (Boehringer Mannheim Diagnostics). We calculated anion gap according to the following equation: Embedded Image

Glomerular filtration rate (GFR) was calculated according to the simplified Modification of Diet in Renal Disease Study prediction equation.20 Specifically, estimated GFR=186.3×(serum creatinine in mg/dL)−1.154×age−0.203× 0.742 if female)×(1.21 if black). We corrected serum creatinine in the NHANES 1999–2000 sample to align creatinine values with the creatinine assay used in the development of the Modification of Diet in Renal Disease Study equation.21,22 Serum creatinine in the NHANES 2001–2002 sample did not require correction.

Measurement of Blood Pressure

Blood pressure was determined by mercury sphygmomanometer according to American Heart Association guidelines.23 Three or 4 blood pressure determinations (systolic and diastolic) were taken on all of the eligible individuals. The arithmetic mean of blood pressure recordings was used as the blood pressure.

Statistical Analyses

Because older individuals, Mexican Americans, and black individuals were intentionally overrepresented, NHANES 1999–2000 and 2001–2002 were not simple random samples of the US population. Therefore, appropriate sample weights were used to obtain weighted regression estimates, and the final results of our analyses are generalizable to the US population.

For our analyses, we excluded participants with self-reported chronic diseases, including hypertension, chronic kidney disease, diabetes mellitus, congestive heart failure, coronary artery disease, myocardial infarction, angina, cerebrovascular disease, and cancer (except nonmelanoma skin cancer), as well as those taking antihypertensive medications or diuretics. We divided the serum anion gap into quintiles. Within each quintile of anion gap, we calculated the percentage of each categorical demographic characteristic and the mean value (±SE) of age, BMI, each laboratory measurement, and blood pressure. Race-ethnicity was predefined in NHANES 1999–2000 and 2001–2002 as non-Hispanic white, non-Hispanic black, Mexican American, or other. In linear regression analyses, systolic and diastolic blood pressures were examined as dependent variables, with quintiles of serum anion gap (or continuous anion gap) as the independent variables. Covariates considered were age; gender; race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, other); BMI (continuous); smoking (current, past, or never); serum levels of creatinine, albumin, calcium, and potassium (continuous); and daily intakes of total protein and potassium (continuous). We calculated 95% CIs for parameter estimates of both systolic and diastolic blood pressure. Tests of trend were calculated across quintiles of anion gap with the median value of each quintile serving as an ordinal variable. All Ps were 2 sided. We also used logistic regression to calculate the odds ratio (OR) and 95% CIs of abnormal blood pressure (defined by the seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure as systolic blood pressure ≥120, diastolic blood pressure ≥80, or both1) by quintile of anion gap. We performed similar analyses with bicarbonate, rather than anion gap, as the independent variable.

Data analysis was performed with SAS 9.1 and SUDAAN 9.0. Protocols to recruit and study participants of NHANES 1999–2000 and NHANES 2001–2002 were reviewed and approved by the National Center for Health Statistics Institutional Review Board.

Results

A total of 9832 participants aged ≥18 years had complete measurements of serum electrolytes and creatinine and denied the use of antihypertensive medications or diuretics. After excluding individuals with self-reported hypertension, chronic kidney disease, diabetes mellitus, congestive heart failure, coronary artery disease, myocardial infarction, angina, cerebrovascular disease, and cancer (except nonmelanoma skin cancer) and individuals with measured albumin <3.5 g/dL and/or measured calcium >10.5 mmol/L, there were 5043 participants remaining in the study population. Characteristics of these participants are shown in Table 1. Because the relations among anion gap, serum bicarbonate, and blood pressure did not vary by sex, results for men and women were combined.

View this table:
  • View inline
  • View popup

TABLE 1. Cohort Characteristics by Quintile of Anion Gap

Serum anion gap was positively associated with systolic blood pressure in age-adjusted and multivariable-adjusted analyses (Table 2). After adjusting for age, gender, race, BMI, creatinine, and albumin, systolic blood pressure increased by 0.48 mm Hg (95% CI: 0.28 to 0.69 mm Hg) for each milliequivalent-per-liter increase in serum anion gap. After multivariable adjustment, participants in the highest quintile of anion gap had systolic blood pressure 3.73 mm Hg higher (95% CI: 1.83 to 5.63 mm Hg; P for trend: <0.01) than participants in the lowest quintile. The relation between anion gap and diastolic blood pressure was not statistically significant. The multivariable-adjusted OR of abnormal blood pressure (systolic blood pressure ≥120, diastolic blood pressure ≥80, or both)1 was 1.68 (95% CI: 1.18 to 2.41; P for trend: <0.01) for participants in the highest quintile of serum anion gap compared with those in the lowest quintile.

View this table:
  • View inline
  • View popup

TABLE 2. Predicted Change in Systolic and Diastolic Blood Pressure by Single Units and Quintiles of Anion Gap

We also evaluated the relation between serum bicarbonate and blood pressure. To determine the association between bicarbonate and blood pressure independent of serum sodium and chloride concentrations, we included serum sodium and chloride in the multivariable models. After adjusting for age, gender, race, BMI, creatinine, albumin, sodium, and chloride, systolic blood pressure increased by 0.46 mm Hg (95% CI: 0.23 to 0.69 mm Hg) for each milliequivalent-per-liter decrease in bicarbonate. After multivariable adjustment, participants in the highest quintile of bicarbonate (mean: 26.8 mEq/L) had systolic blood pressure 2.73 mm Hg lower (95% CI: 1.26 to 4.20 mm Hg; P for trend: <0.01) than participants in the lowest quintile of bicarbonate (mean: 20.2 mEq/L). The relation between bicarbonate and diastolic blood pressure was not statistically significant.

Finally, we performed analyses excluding the 126 participants with chronic kidney disease (defined by calculated GFR <60 cc/min per 1.73 m2) from our sample (Table 3). The results were similar to the primary analysis. After adjusting for age, gender, race, BMI, creatinine, and albumin, participants in the highest quintile of anion gap had systolic blood pressure 3.70 mm Hg higher (95% CI: 1.75 to 5.66 mm Hg; P for trend: <0.01) than participants in the lowest quintile. Further adjustment for smoking, serum calcium, serum potassium, and dietary intake of total protein and potassium did not materially change the results.

View this table:
  • View inline
  • View popup

TABLE 3. Predicted Change in Systolic and Diastolic Blood Pressure by Single Units and Quintiles of Anion Gap Where GFR ≥60 cc/min per 1.73 m2

Discussion

In adult participants of NHANES 1999–2002, higher levels of serum anion gap were associated with higher blood pressure. This relation was independent of age, gender, race, BMI, and levels of serum creatinine and albumin. Because our study excluded participants who reported cardiovascular disease, hypertension, kidney disease, diabetes, or other diseases and excluded participants taking antihypertensive medications or diuretics, it is unlikely that illness or medication use confounded the observed relation between serum anion gap and blood pressure. Of note, the mean values of serum electrolytes and blood pressure in our study were in ranges considered normal.

The cause of the observed association between higher anion gap and higher blood pressure is unknown. Elevations in the serum anion gap can result from an increase in unmeasured anions, as in several causes of metabolic acidosis, or from a decrease in unmeasured cations.24 In general, reductions in serum calcium and potassium concentrations are unusual causes of an elevated anion gap,24 and in our study the relation between anion gap and blood pressure was unchanged after adjustment for these cations. Serum albumin can also affect the anion gap,25 but we excluded individuals with low serum albumin, and we adjusted for albumin in the multivariate analyses. A mild elevation in anion gap has been reported in metabolic alkalosis,26 but we are unaware of data linking metabolic alkalosis to higher blood pressure, and in our study higher serum bicarbonate was not associated with higher blood pressure.

It is possible that the participants in our study with higher anion gap had a circulating unmeasured anion that contributed to higher blood pressure. The inverse relation between serum bicarbonate and blood pressure suggests that such an anion, if present, may be the conjugate base of an organic acid. Of interest, metabolic acidosis, increased renal acid excretion, and increased metabolic production of acid have been reported in rat models of hypertension. For example, lower plasma pH and bicarbonate have been reported in spontaneously hypertensive rats and Milan hypertensive rats compared with Wistar Kyoto and Milan normotensive control rats.11,12 Metabolic acidosis preceded the development of hypertension in young spontaneously hypertensive rats, suggesting that the acid-base changes were not the product of elevated blood pressure or associated renal insufficiency.12 Metabolic studies of Dahl/Rapp salt-sensitive and salt-resistant control rats on both high- and low-salt diets have demonstrated increased urinary acid excretion in salt-sensitive compared with salt-resistant control rats.13 Of note, the higher levels of acid excretion in the Dahl/Rapp salt-sensitive rats appeared to be because of increased metabolic production of acid.13

Human data suggesting a possible link between organic acid production and high blood pressure are sparse but provocative. In a metabolic study of 40 healthy normotensive young men consuming controlled diets, there was an inverse association between increases in blood pressure induced by a high-sodium diet and both arterial pH and serum bicarbonate (of note, levels of arterial pH and bicarbonate were in ranges considered normal in both salt-sensitive and salt-resistant participants).15 The investigators then administered an ammonium chloride load to a subset of these study participants, who again consumed controlled high- and low-sodium diets.14 There was no difference in renal net acid excretion between the salt-sensitive and salt-resistant groups, suggesting that the relative metabolic acidosis in salt-sensitive individuals was a result of increased production of acid rather than a defect in renal acid excretion.

More recent data are also consistent with the hypothesis that increased metabolic production of acid results in higher blood pressure. The excretion of urinary citrate is regulated most prominently by acid-base status (acidosis results in a marked reduction in urinary citrate),16 and hypertensive individuals excrete less urinary citrate than normotensive control subjects.17 In >3000 participants in the Nurses’ Health Study I, the Nurses’ Health Study II, and the Health Professionals Follow-up Study, the multivariable ORs of prevalent hypertension for those in the highest quartile of 24-hour urinary citrate excretion compared with the lowest quartile were 0.37 (95% CI: 0.24 to 0.55; P for trend: <0.001) in Nurses’ Health Study I, 0.54 (95% CI: 0.32 to 0.92; P for trend: 0.03) in Nurses’ Health Study II, and 0.27 (95% CI: 0.16 to 0.45; P for trend: <0.001) in Health Professionals Follow-up Study.17 These results were adjusted for age, weight, the intake of animal protein and potassium, and urinary factors including calcium, citrate, oxalate, uric acid, sodium, magnesium, potassium, phosphorus, creatinine, pH, and total volume. Finally, we suggest, in a broad and purely speculative fashion, that the higher blood pressures observed after administration of sodium chloride versus sodium bicarbonate or sodium citrate27–30 may represent a protective effect of alkali on sodium-mediated increases in blood pressure.

Our study has limitations. Because the data are cross-sectional, we cannot conclude that an elevated serum anion gap is a risk factor for the development of higher blood pressure. Instead, it is possible that higher blood pressure results in an elevated anion gap because of an unknown mechanism. An important limitation to any study of serum electrolytes and blood pressure is that reduced kidney function is associated with higher anion gap, lower levels of serum bicarbonate, and elevated blood pressure. Previous NHANES data demonstrated that serum anion gap started to increase and serum bicarbonate levels started to decrease when estimated glomerular filtration was <20 cc/min.31 However, in our study we excluded participants with self-reported chronic kidney disease, and we adjusted our analyses for serum creatinine. In addition, we performed analyses excluding participants with chronic kidney disease, as defined by a calculated GFR <60 cc/min per 1.73 m2.32 Another limitation is that medications, such as diuretics, can affect both serum bicarbonate levels and blood pressure. However, we excluded participants who reported the use of such medications. An additional limitation is that study participants were not eating controlled diets. Net endogenous acid production is affected by diet,33 and dietary factors play an important role in blood pressure.34 However, the primary dietary determinants of net endogenous acid production are total protein and potassium,35 and adjustment for the intake of these factors did not change our results. Finally, we did not have measurements of arterial pH or partial pressure of carbon dioxide, and we did not have urinary parameters to measure renal net acid excretion. Thus, we are unable to fully assess the acid-base status of the participants in the study.

Perspectives

Higher serum anion gap is independently associated with higher blood pressure. Prospective studies of the relation between serum anion gap and incident hypertension are needed. Our data provide support for the hypothesis that increased production of organic acid plays a role in hypertension and should encourage further research into the relation between acid-base metabolism and blood pressure.

Acknowledgments

Source of Funding

Research support was obtained from grant DK73381 from the National Institutes of Health.

Disclosures

None.

  • Received April 18, 2007.
  • Revision received May 8, 2007.
  • Accepted May 18, 2007.

References

  1. ↵
    Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42: 1206–1252.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 2004; 44: 398–404.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Fiebach NH, Hebert PR, Stampfer MJ, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH. A prospective study of high blood pressure and cardiovascular disease in women. Am J Epidemiol. 1989; 130: 646–654.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360: 1903–1913.
    OpenUrlCrossRefPubMed
  5. ↵
    MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990; 335: 765–774.
    OpenUrlCrossRefPubMed
  6. ↵
    Vasan RS, Larson MG, Leip EP, Evans JC, O’Donnell CJ, Kannel WB, Levy D. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001; 345: 1291–1297.
    OpenUrlCrossRefPubMed
  7. ↵
    Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, Rogers NL, Teschan PE. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int. 1997; 51: 1908–1919.
    OpenUrlCrossRefPubMed
  8. ↵
    Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA. 1997; 277: 1293–1298.
    OpenUrlCrossRefPubMed
  9. ↵
    Walker WG. Hypertension-related renal injury: a major contributor to end-stage renal disease. Am J Kidney Dis. 1993; 22: 164–173.
    OpenUrlPubMed
  10. ↵
    Sharma AM, Distler A. Acid-base abnormalities in hypertension. Am J Med Sci. 1994; 307 (suppl 1): S112–S115.
    OpenUrlCrossRefPubMed
  11. ↵
    Lucas PA, Lacour B, Comte L, McCarron DA, Drueke T. Abnormal parameters of acid-base balance in genetic hypertension. Kidney Int. 1988; 25 (suppl): S19–S22.
    OpenUrl
  12. ↵
    Lucas PA, Lacour B, McCarron DA, Drueke T. Disturbance of acid-base balance in the young spontaneously hypertensive rat. Clin Sci (Lond). 1987; 73: 211–215.
    OpenUrlPubMed
  13. ↵
    Batlle DC, Sharma AM, Alsheikha MW, Sobrero M, Saleh A, Gutterman C. Renal acid excretion and intracellular pH in salt-sensitive genetic hypertension. J Clin Invest. 1993; 91: 2178–2184.
    OpenUrlCrossRefPubMed
  14. ↵
    Sharma AM, Cetto C, Schorr U, Spies KP, Distler A. Renal acid-base excretion in normotensive salt-sensitive humans. Hypertension. 1993; 22: 884–890.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Sharma AM, Kribben A, Schattenfroh S, Cetto C, Distler A. Salt sensitivity in humans is associated with abnormal acid-base regulation. Hypertension. 1990; 16: 407–413.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Hamm LL. Renal handling of citrate. Kidney Int. 1990; 38: 728–735.
    OpenUrlCrossRefPubMed
  17. ↵
    Taylor EN, Mount DB, Forman JP, Curhan GC. Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors. Am J Kidney Dis. 2006; 47: 780–789.
    OpenUrlCrossRefPubMed
  18. ↵
    National Center for Health Statistics. National Health and Nutrition Examination Survey Data. Hyattsville, MD: National Center for Health Statistics, US Department of Health and Human Services, Centers for Disease Control and Prevention, 1999–2000.
  19. ↵
    National Center for Health Statistics. National Health and Nutrition Examination Survey Data. Hyattsville, MD: National Center for Health Statistics, US Department of Health and Human Services, Centers for Disease Control and Prevention, 2001–2002.
  20. ↵
    National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39: S1–S266.
    OpenUrlCrossRefPubMed
  21. ↵
    Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, Levey AS. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002; 39: 920–929.
    OpenUrlCrossRefPubMed
  22. ↵
    Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005; 16: 180–188.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M, Morgenstern BZ. Human blood pressure determination by sphygmomanometry. Circulation. 1993; 88: 2460–2470.
    OpenUrlFREE Full Text
  24. ↵
    Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders. New York, NY: McGraw-Hill, 2001.
  25. ↵
    Figge J, Jabor A, Kazda A, Fencl V. Anion gap and hypoalbuminemia. Crit Care Med. 1998; 26: 1807–1810.
    OpenUrlPubMed
  26. ↵
    Madias NE, Ayus JC, Adrogue HJ. Increased anion gap in metabolic alkalosis: the role of plasma-protein equivalency. N Engl J Med. 1979; 300: 1421–1423.
    OpenUrlCrossRefPubMed
  27. ↵
    Kurtz TW, Al-Bander HA, Morris RC Jr. “Salt-sensitive” essential hypertension in men. Is the sodium ion alone important? N Engl J Med. 1987; 317: 1043–1048.
    OpenUrlCrossRefPubMed
  28. ↵
    Kurtz TW, Morris RC Jr. Dietary chloride as a determinant of “sodium-dependent” hypertension. Science. 1983; 222: 1139–1141.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    Luft FC, Steinberg H, Ganten U, Meyer D, Gless KH, Lang RE, Fineberg NS, Rascher W, Unger T, Ganten D. Effect of sodium chloride and sodium bicarbonate on blood pressure in stroke-prone spontaneously hypertensive rats. Clin Sci (Lond). 1988; 74: 577–585.
    OpenUrlPubMed
  30. ↵
    Luft FC, Zemel MB, Sowers JA, Fineberg NS, Weinberger MH. Sodium bicarbonate and sodium chloride: effects on blood pressure and electrolyte homeostasis in normal and hypertensive man. J Hypertens. 1990; 8: 663–670.
    OpenUrlCrossRefPubMed
  31. ↵
    Hsu CY, Chertow GM. Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. Nephrol Dial Transplant. 2002; 17: 1419–1425.
    OpenUrlAbstract/FREE Full Text
  32. ↵
    Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67: 2089–2100.
    OpenUrlCrossRefPubMed
  33. ↵
    Kurtz I, Maher T, Hulter HN, Schambelan M, Sebastian A. Effect of diet on plasma acid-base composition in normal humans. Kidney Int. 1983; 24: 670–680.
    OpenUrlCrossRefPubMed
  34. ↵
    Pickering TG. New guidelines on diet and blood pressure. Hypertension. 2006; 47: 135–136.
    OpenUrlFREE Full Text
  35. ↵
    Frassetto LA, Todd KM, Morris RC Jr, Sebastian A. Estimation of net endogenous noncarbonic acid production in humans from diet potassium and protein contents. Am J Clin Nutr. 1998; 68: 576–583.
    OpenUrlAbstract
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Hypertension
August 2007, Volume 50, Issue 2
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Serum Anion Gap and Blood Pressure in the National Health and Nutrition Examination Survey
    Eric N. Taylor, John P. Forman and Wildon R. Farwell
    Hypertension. 2007;50:320-324, originally published July 18, 2007
    https://doi.org/10.1161/HYPERTENSIONAHA.107.092643

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Hypertension.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Serum Anion Gap and Blood Pressure in the National Health and Nutrition Examination Survey
    (Your Name) has sent you a message from Hypertension
    (Your Name) thought you would like to see the Hypertension web site.
  • Share on Social Media
    Serum Anion Gap and Blood Pressure in the National Health and Nutrition Examination Survey
    Eric N. Taylor, John P. Forman and Wildon R. Farwell
    Hypertension. 2007;50:320-324, originally published July 18, 2007
    https://doi.org/10.1161/HYPERTENSIONAHA.107.092643
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Cardiology
    • Etiology
      • Hypertension
        • Hypertension
  • Epidemiology, Lifestyle, and Prevention
    • Epidemiology
  • Basic, Translational, and Clinical Research
    • Etiology
    • Clinical Studies

Hypertension

  • About Hypertension
  • Instructions for Authors
  • AHA CME
  • Guidelines and Statements
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
7272 Greenville Ave.
Dallas, TX 75231
email: hypertension@heart.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured